OVARIAN NEOPLASMS
Clinical trials for OVARIAN NEOPLASMS explained in plain language.
Never miss a new study
Get alerted when new OVARIAN NEOPLASMS trials appear
Sign up with your email to follow new studies for OVARIAN NEOPLASMS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New cancer drug trial seeks to tame advanced tumors
Disease control TerminatedThis early-stage study tested a new drug called Felmetatug Vedotin, both alone and combined with pembrolizumab, in people with advanced solid tumors that had spread or could not be removed by surgery. The main goal was to find safe dosage levels and understand side effects for ca…
Matched conditions: OVARIAN NEOPLASMS
Phase: PHASE1 • Sponsor: Seagen, a wholly owned subsidiary of Pfizer • Aim: Disease control
Last updated Apr 03, 2026 14:42 UTC
-
Study tests new drug combo against standard chemo for tough ovarian cancers
Disease control TerminatedThis study aimed to compare two different drug treatments given before surgery for advanced ovarian cancer. Researchers tested whether a newer targeted drug called niraparib worked better than standard platinum-taxane chemotherapy for patients with specific genetic features in th…
Matched conditions: OVARIAN NEOPLASMS
Phase: PHASE2 • Sponsor: Tesaro, Inc. • Aim: Disease control
Last updated Apr 02, 2026 14:57 UTC
-
New pill tested as potential lifeline for Tough-to-Treat cancers
Disease control TerminatedThis early-stage study tested a new oral drug called NKT3447 in adults with advanced solid tumors that had progressed despite standard treatments. The main goals were to find a safe dose and see how the body processes the drug. The study was later terminated and focused on specif…
Matched conditions: OVARIAN NEOPLASMS
Phase: PHASE1 • Sponsor: NiKang Therapeutics, Inc. • Aim: Disease control
Last updated Mar 27, 2026 12:39 UTC